Nicotine Addiction
57
9
11
37
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
24 trials with published results (42%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
5.3%
3 terminated out of 57 trials
92.5%
+5.9% vs benchmark
18%
10 trials in Phase 3/4
65%
24 of 37 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 37 completed trials
Clinical Trials (57)
Sex Differences in E-cig Perception: Study 1
Metabolome and Gut Microbiome Changes During Smoking Cessation in Long-term Drug Therapy in a Therapeutic Community
Assess the Influence of Nicotine Flux and Nicotine Form on Subjective Effects Related to Dependency
Evaluation of a Smoking Cessation Program for Long-Term Abstinence
Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)
Semaglutide for Smoking Cessation in Patients With Diabetes
Impact of Appointment Reminder Strategies on Smoking Cessation Clinic Attendance
Acute Pharmacokinetic and Pharmacodynamic Effects of "Tobacco-Free" Oral Nicotine Pouches in Smokers
CONNECT Cancer Survivors With Tobacco Treatment
Non-Invasive Deep Brain Neuromodulation for Smoking Cessation
Factors Sustaining Tobacco Abstinence in Cancer Patients Treated With Radio-chemotherapy or Radiotherapy
Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder
Effect of Product Characteristics on the Abuse Liability of Nicotine Pouches
Developing Evidence to Inform Regulatory Policy on Nicotine Content in E-Liquids
Effects of Semaglutide on Nicotine Intake
A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults
Quit Smoking Study for People Who Use E-Cigarettes
Neural Mechanisms Associated With Risk of Smoking Relapse
Nicotine's Effect on Cancer Stem Cell Markers in Human Umbilical Cord Tissue
Electronic Cigarettes as a Harm Reduction Strategy Among People Living With HIV/AIDS